Jimeno J - Search Results

1

PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies.

Soler-Agesta R, Marco-Brualla J, Minjárez-Sáenz M, Yim CY, Martínez-Júlvez M, Price MR, Moreno-Loshuertos R, Ames TD, Jimeno J, Anel A. Soler-Agesta R, et al. Among authors: jimeno j. Cancers (Basel). 2022 Aug 9;14(16):3851. doi: 10.3390/cancers14163851. Cancers (Basel). 2022. PMID: 36010843 Free PMC article.

2

Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours.

Karp DD, Camidge DR, Infante JR, Ames TD, Price MR, Jimeno J, Bryce AH. Karp DD, et al. Among authors: jimeno j. EClinicalMedicine. 2022 May 27;49:101430. doi: 10.1016/j.eclinm.2022.101430. eCollection 2022 Jul. EClinicalMedicine. 2022. PMID: 35747193 Free PMC article.

3

Phase I and pharmacokinetic study of trabectedin as a 1- or 3-hour infusion weekly in patients with advanced solid malignancies.

Forouzesh B, Hidalgo M, Chu Q, Mita A, Mita M, Schwartz G, Jimeno J, Gómez J, Alfaro V, Lebedinsky C, Zintl P, Rowinsky EK. Forouzesh B, et al. Among authors: jimeno j. Clin Cancer Res. 2009 May 15;15(10):3591-9. doi: 10.1158/1078-0432.CCR-08-2889. Epub 2009 May 5. Clin Cancer Res. 2009. PMID: 19417019 Clinical Trial.

4

Phase II study with high doses of epirubicin in patients with advanced rectal cancer.

Alberola V, García Conde J, Jimeno J, Fernandez Martos C, Herranz C, Macheng I, Centelles M, Sánchez J. Alberola V, et al. Among authors: jimeno j. Tumori. 1990 Oct 31;76(5):503-4. doi: 10.1177/030089169007600518. Tumori. 1990. PMID: 2256199 Clinical Trial.

5

A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies.

Villalona-Calero MA, Eckhardt SG, Weiss G, Hidalgo M, Beijnen JH, van Kesteren C, Rosing H, Campbell E, Kraynak M, Lopez-Lazaro L, Guzman C, Von Hoff DD, Jimeno J, Rowinsky EK. Villalona-Calero MA, et al. Among authors: jimeno j. Clin Cancer Res. 2002 Jan;8(1):75-85. Clin Cancer Res. 2002. PMID: 11801542 Clinical Trial.

6

Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.

Izquierdo MA, Bowman A, García M, Jodrell D, Martinez M, Pardo B, Gómez J, López-Martin JA, Jimeno J, Germá JR, Smyth JF. Izquierdo MA, et al. Among authors: jimeno j. Clin Cancer Res. 2008 May 15;14(10):3105-12. doi: 10.1158/1078-0432.CCR-07-1652. Clin Cancer Res. 2008. PMID: 18483378 Clinical Trial.

7

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma.

Laverdiere C, Kolb EA, Supko JG, Gorlick R, Meyers PA, Maki RG, Wexler L, Demetri GD, Healey JH, Huvos AG, Goorin AM, Bagatell R, Ruiz-Casado A, Guzman C, Jimeno J, Harmon D. Laverdiere C, et al. Among authors: jimeno j. Cancer. 2003 Aug 15;98(4):832-40. doi: 10.1002/cncr.11563. Cancer. 2003. PMID: 12910529 Free article. Clinical Trial.

8

Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours.

Twelves C, Hoekman K, Bowman A, Vermorken JB, Anthoney A, Smyth J, van Kesteren C, Beijnen JH, Uiters J, Wanders J, Gomez J, Guzmán C, Jimeno J, Hanauske A. Twelves C, et al. Among authors: jimeno j. Eur J Cancer. 2003 Sep;39(13):1842-51. doi: 10.1016/s0959-8049(03)00458-1. Eur J Cancer. 2003. PMID: 12932661 Clinical Trial.

9

A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.

Lau L, Supko JG, Blaney S, Hershon L, Seibel N, Krailo M, Qu W, Malkin D, Jimeno J, Bernstein M, Baruchel S. Lau L, et al. Among authors: jimeno j. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):672-7. Clin Cancer Res. 2005. PMID: 15701855 Clinical Trial.

10

Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy.

Garcia-Carbonero R, Supko JG, Manola J, Seiden MV, Harmon D, Ryan DP, Quigley MT, Merriam P, Canniff J, Goss G, Matulonis U, Maki RG, Lopez T, Puchalski TA, Sancho MA, Gomez J, Guzman C, Jimeno J, Demetri GD. Garcia-Carbonero R, et al. Among authors: jimeno j. J Clin Oncol. 2004 Apr 15;22(8):1480-90. doi: 10.1200/JCO.2004.02.098. J Clin Oncol. 2004. PMID: 15084621 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page